GanD, Inc.

Miami Beach, FL · Medtech · Still private

GND resuscitation fluid for severe hemorrhage treatment

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Miami Beach, FL
Total capital
$1.1M
Federal grants
$1.1M
1 award · 2022
Rank in peer group#27 of 30
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
6 pending · first 2025
Rank in peer group#10 of 30

Capital timeline

2022FEDERAL ↑EQUITY ↓Cumulative $1.1M$1.1M
2022FEDERAL ↑EQUITY ↓Cumulative $1.1M$1.1M

Latest events

  • Federal grantDefense · Phase II · Complex Crystalloid Resuscitative Fluid$1.1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 30 peers

Line = median

Medtech · Molecule

  • Federal grantsBelow median
  • Granted patents#10 · top 33%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 7
  • PendingBioactive Fluid CompositionsUSPTOApplication 19233798
  • GrantedBioactive Fluid CompositionsUSPTOUS 12,419,850
  • PendingBioactive Fluid CompositionsUSPTOApplication 19087033
Show all 7 patent records
  • Bioactive Fluid CompositionsOct 2, 2025 · Application 19233798Pending
  • Bioactive Fluid CompositionsSep 23, 2025 · US 12,419,850Granted
  • Bioactive Fluid CompositionsJul 31, 2025 · Application 19087033Pending
  • Resuscitation FluidApplication 16201114Pending
  • Bioactive Fluid CompositionsApplication 18612800Pending
  • Bioactive Fluid CompositionsApplication PCTUS2025020879Pending
  • Methods and Compositions For Protecting Endothelial CellsApplication 17475615Pending
  • IF, LLCSimilar federal contract value in Medtech · null in contracts
  • AMDX PROGNOSTX INCORPORATEDSimilar federal contract value in Medtech · null in contracts
  • QUASISTATICS INCSimilar federal contract value in Medtech · null in contracts
  • MADORRA INC.Similar federal contract value in Medtech · null in contracts
  • Sparta ScienceSimilar federal contract value in Medtech · null in contracts
  • QUANT, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .